Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age

By Ceyhan M.   Kanra G.   Erdem G.   Kanra B.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4473-4478

Elsevier

Access to resources Recommend Favorite

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G.   Gay N.J.   Hesketh L.M.   Vyse A.   Morgan-Capner P.   Brown D.W.   Litton P.   Miller E.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite

Reactogenicity and immunogenicity of a new combined Measles-Mumps-Rubella vaccine: results of a multicentre trial

By Crovari P.   Gabutti G.   Giammanco G.   Dentico P.   Moiraghi A.R.   Ponzio F.   Soncini R.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2796-2803

Elsevier

Access to resources Recommend Favorite

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

By Nolan T.   McIntyre P.   Roberton D.   Descamps D.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 281-289

Elsevier

Access to resources Recommend Favorite

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months

By Bottiger M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1759-1762

Elsevier

Access to resources Recommend Favorite